Unicycive Therapeutics, Inc.$4.73 %
Analyst Rating: Hold
Stock Details
CEO
Shalabh K. Gupta MPA
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
22
Address
4300 El Camino Real, Los Altos, CA, 94022
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Top Competitors
Income Statement
Financials
Selected Year